Breakthrough in Device Therapy for Patients with Late-Stage Heart Disease

2 years ago

SWANSEA, Wales and TEL AVIV, Israel, Jan. 10, 2022 /PRNewswire/ -- Severe heart failure is the most life-threatening medical condition in…

Fortified Health Security CEO Dan L. Dodson Elected to the Association for Executives in Healthcare Information Security (AEHIS) Board of Trustees

2 years ago

Joins group of prominent healthcare cybersecurity visionaries in advancing organization's mission of serving senior IT executives while advocating for the…

Mercator MedSystems Announces Receipt of NIH Grant for Research and Development of Local Anti-inflammatory Deep Vein Thrombosis Therapy

2 years ago

EMERYVILLE, CA / ACCESSWIRE / January 10, 2022 / Mercator MedSystems, Inc. ("Mercator" or the "company"), announced today that research…

Eyam Vaccines and Immunotherapeutics Welcomes New Board Members and Scientific Advisors

2 years ago

VANCOUVER, BC / ACCESSWIRE / January 10, 2022 / Eyam Vaccines and Immunotherapeutics is pleased to publicly announce the appointment…

Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch

2 years ago

ORLANDO, FL / ACCESSWIRE / January 10, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the signing of a feasibility agreement…

Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update

2 years ago

807 million doses of Moderna's COVID-19 vaccine shipped globally in 2021; approximately 25% of those doses shipped to low- and…

Zomedica CEO Provides Update to Shareholders

2 years ago

ANN ARBOR, MI / ACCESSWIRE / January 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology

2 years ago

Collaboration will combine Carisma's engineered macrophage technology with Moderna's mRNA and LNP technologies to generate and develop in vivo CAR-M…

NeuroMetrix Names Strategic Growth Executive, Brandi Damkier, as Vice President, Clinical Partnerships

2 years ago

WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has appointed Brandi Damkier…

NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal and Liver and Metabolic Programs

2 years ago

After a transformative year in 2021, NGM Bio enters 2022 with a diverse pipeline of seven disclosed programs, including four…